Medical consumable abnormal data type-2 fuzzy screening method based on cross-domain collaboration and isomerism map
By employing a type II fuzzy screening method for abnormal medical consumable data based on cross-domain collaboration and heterogeneous graphs, combined with NLP, cross-domain transfer learning, and graph neural networks, the problem of inconsistent features in local medical consumable data was solved, achieving efficient screening and repair of abnormal data.
Patent Information
- Application Number
- CN202511504814.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-10-21
- Publication Date
- 2025-11-18
- Estimated Expiration
- 2045-10-21
AI Technical Summary
The current discrepancy between local and national medical consumables data leads to slow processing speeds and low accuracy. Existing technologies are unable to effectively screen products with inconsistent characteristics, causing challenges to data governance.
A type II fuzzy screening method for abnormal medical consumable data based on cross-domain collaboration and heterogeneous graphs is adopted. Through a three-level governance framework combined with NLP, cross-domain transfer learning, graph neural networks and type II fuzzy systems, a deep learning model is constructed to screen and repair abnormal data.
It improves the judgment accuracy of cross-domain transfer learning, achieves high precision in anomaly screening and accurate data repair, and enhances the decision-maker's adaptability to high-dimensional dynamic data.